These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18030752)

  • 1. [Characteristics of lipid composition of blood serum lipoproteins in insulin resistance].
    Sokolik VV; Chursina VS; Rodenko OS; Bozhko GKh
    Ukr Biokhim Zh (1999); 2007; 79(2):62-9. PubMed ID: 18030752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
    Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
    Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus.
    Attia N; Touzani A; Lahrichi M; Balafrej A; Kabbaj O; Girard-Globa A
    Diabet Med; 1997 Mar; 14(3):242-7. PubMed ID: 9088774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of metabolic control on plasma lipids and lipoproteins in insulin-dependent diabetes in children and adolescents].
    Jos J; Thévenin M; Dumont G; Beyne P
    Diabete Metab; 1985 Jun; 11(3):174-80. PubMed ID: 3928411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fish oil concentrate on lipoprotein composition in NIDDM.
    Schectman G; Kaul S; Kissebah AH
    Diabetes; 1988 Nov; 37(11):1567-73. PubMed ID: 3181646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).
    Alaupovic P; Hodis HN; Knight-Gibson C; Mack WJ; LaBree L; Cashin-Hemphill L; Corder CN; Kramsch DM; Blankenhorn DH
    Arterioscler Thromb; 1994 Dec; 14(12):1906-13. PubMed ID: 7981178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal and maternal lipoprotein metabolism in human pregnancy complicated by type I diabetes mellitus.
    Kilby MD; Neary RH; Mackness MI; Durrington PN
    J Clin Endocrinol Metab; 1998 May; 83(5):1736-41. PubMed ID: 9589684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein abnormalities in well-treated type II diabetic patients.
    Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
    Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
    Julier K; Mackness MI; Dean JD; Durrington PN
    Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment.
    Gylling H; Miettinen TA
    Diabetologia; 1994 Aug; 37(8):773-80. PubMed ID: 7988779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids and lipoproteins in type 2 diabetic patients with persistent microalbuminuria.
    Seghieri G; Alviggi L; Caselli P; De Giorgio LA; Breschi C; Gironi A; Niccolai M; Bartolomei GC
    Diabet Med; 1990 Nov; 7(9):810-4. PubMed ID: 2148134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of abnormal composition of lipoproteins to HbA1c levels in non-insulin dependent diabetes.
    Sánchez-Cabezudo M; Ródenas S; Cuesta C
    Rev Esp Fisiol; 1994 Sep; 50(3):145-51. PubMed ID: 7886271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and lipoprotein aberrations in Indian patients with non-insulin-dependent diabetes in the young.
    Jialal I; Deppe W; Joubert SM
    S Afr Med J; 1985 Jun; 67(25):1001-4. PubMed ID: 4012462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control.
    Gonen B; White N; Schonfeld G; Skor D; Miller P; Santiago J
    Metabolism; 1985 Jul; 34(7):675-9. PubMed ID: 3874341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.
    Kadoglou NP; Fotiadis G; Athanasiadou Z; Vitta I; Lampropoulos S; Vrabas IS
    Endocrine; 2012 Dec; 42(3):561-9. PubMed ID: 22407494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus.
    Duvillard L; Pont F; Florentin E; Gambert P; Vergès B
    Diabetologia; 2000 Jan; 43(1):27-35. PubMed ID: 10663213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoproteins, apolipoproteins, and proteins concerned with lipid metabolism.
    Calvert GD; Abbey M
    Adv Clin Chem; 1985; 24():217-98. PubMed ID: 3911751
    [No Abstract]   [Full Text] [Related]  

  • 20. The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activity.
    Kahri J; Fruchart-Najib J; Matikainen N; Fruchart JC; Vakkilainen J; Taskinen MR
    Diabetes Care; 2007 Aug; 30(8):2083-5. PubMed ID: 17485571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.